Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease
Authors
Keywords
(5/6), Cardiovascular diseases, COPD, Emphysema, Heart failure, Type 2 diabetes mellitus
Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 186, Issue -, Pages 109837
Publisher
Elsevier BV
Online
2022-03-19
DOI
10.1016/j.diabres.2022.109837
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction
- (2021) Massar Omar et al. JAMA Cardiology
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2021) Theresa A McDonagh et al. EUROPEAN HEART JOURNAL
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review
- (2020) Ike Iheanacho et al. International Journal of Chronic Obstructive Pulmonary Disease
- Management of the COPD Patient with Comorbidities: An Experts Recommendation Document
- (2020) Jesús Recio Iglesias et al. International Journal of Chronic Obstructive Pulmonary Disease
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of dapagliflozin in heart failure with reduced ejection fraction, and chronic obstructive pulmonary disease: an analysis of DAPA‐HF
- (2020) Pooja Dewan et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial
- (2019) Subodh Verma et al. CIRCULATION
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease
- (2019) Marco Canepa et al. JACC-Heart Failure
- SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
- (2018) Subodh Verma et al. DIABETOLOGIA
- Lung and kidney: a dangerous liaison? A population-based cohort study in COPD patients in Italy
- (2017) Ugo Fedeli et al. International Journal of Chronic Obstructive Pulmonary Disease
- Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality
- (2017) Te-Wei Ho et al. PLoS One
- CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
- (2016) Ele Ferrannini et al. DIABETES CARE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management
- (2015) M. Drummond et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)
- (2014) Bernard Zinman et al. Cardiovascular Diabetology
- Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction
- (2014) Robert J. Mentz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Factors affecting mortality following emergency admission for chronic obstructive pulmonary disease
- (2014) Wakae Hasegawa et al. BMC Pulmonary Medicine
- Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression
- (2010) Samy Suissa et al. AMERICAN JOURNAL OF MEDICINE
- Percent Emphysema, Airflow Obstruction, and Impaired Left Ventricular Filling
- (2010) R. Graham Barr et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients Diagnosed With Diabetes Are at Increased Risk for Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Fibrosis, and Pneumonia but Not Lung Cancer
- (2009) S. F. Ehrlich et al. DIABETES CARE
- Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology
- (2009) Nathaniel Mark Hawkins et al. EUROPEAN JOURNAL OF HEART FAILURE
- Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
- (2008) D. M. Mannino et al. EUROPEAN RESPIRATORY JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started